Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,685,500 | 2,171,300 | 1,984,200 | 1,544,800 | 1,365,500 |
| Marketable Securities | 64,000 | 44,400 | 105,400 | 110,300 | 198,300 |
| Receivables | 1,243,200 | 1,116,300 | 1,123,600 | 1,016,300 | 922,300 |
| Inventories | 627,600 | 576,700 | 494,600 | 482,200 | 472,500 |
| TOTAL | $5,076,400 | $4,341,200 | $4,168,500 | $3,650,600 | $3,385,000 |
| Non-Current Assets | |||||
| PPE Net | 1,163,300 | 1,148,000 | 1,123,500 | 1,095,700 | 1,471,500 |
| Intangibles | 8,381,700 | 8,447,500 | 8,525,000 | 8,598,200 | 8,678,700 |
| Other Non-Current Assets | 2,923,200 | 878,300 | 750,700 | 655,100 | 396,700 |
| TOTAL | $12,468,200 | $10,473,800 | $10,399,200 | $10,349,000 | $10,546,900 |
| Total Assets | $17,544,600 | $14,815,000 | $14,567,700 | $13,999,600 | $13,931,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 126,700 | 126,600 | 126,600 | 126,500 | 93,800 |
| Accounts payable and accrued liabilities | 74,000 | 868,200 | 728,700 | 669,800 | 698,200 |
| Accrued Expenses | 892,700 | N/A | N/A | N/A | N/A |
| Other current liabilities | 100,900 | 96,400 | 176,200 | 147,500 | 132,000 |
| TOTAL | $1,194,300 | $1,091,200 | $1,031,500 | $943,800 | $1,174,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,375,000 | 2,406,700 | 2,438,300 | 2,470,000 | 2,501,700 |
| aiOther Non-Current Liabilities | 622,100 | 635,200 | 593,200 | 573,100 | 338,800 |
| TOTAL | $5,078,500 | $3,356,600 | $3,372,700 | $3,349,200 | $3,592,600 |
| Total Liabilities | $6,272,800 | $4,447,800 | $4,404,200 | $4,293,000 | $4,766,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 221,401 | 221,291 | 224,227 | 224,237 | 223,469 |
| Retained earnings | 4,639,800 | 3,750,800 | 3,283,200 | 2,823,400 | 2,325,800 |
| Other shareholders' equity | -66,700 | -48,600 | -57,700 | -20,700 | -9,600 |
| TOTAL | $11,271,800 | $10,367,200 | $10,163,500 | $9,706,600 | $9,165,300 |
| Total Liabilities And Equity | $17,544,600 | $14,815,000 | $14,567,700 | $13,999,600 | $13,931,900 |